Charlene Huang

Ms. Huang is specialized in foreign investment and M&A. She has been actively involved in advising multinational companies on their corporate governance, daily operation and compliance, has an extensive knowledge and experience in life-science and healthcare industry. The clients Ms. Huang regularly represents include listed or multinational pharmaceutical companies, leading medical device enterprises, medical institutions, state-owned group companies and various foreign investors.

Ms. Huang has advised on projects including equity acquisition by foreign/sate-owned/private investors, integration and restructuring of MNC’s pipelines, license or cooperation project in pharmaceutical and medical service sectors. She continually advises and represents GSK, Abbott, Align (Invisalign), Boehringer-Ingelheim, Lilly, SIIC, Lv Ye Pharm in daily operation and innovative projects (gene therapy, digital medicine, AI medical, internet healthcare, etc).

Ms. Huang has also advised both Chinese and international companies on compliance assessment and risk control, especially anti-corruption and cybersecurity.